Journal article
A Critical Look at Local-Regional Management of Peritoneal Metastasis
Hematology/oncology clinics of North America, Vol.29(1), pp.153-158
02/2015
DOI: 10.1016/j.hoc.2014.09.006
PMID: 25475577
Abstract
For patients with stage IV colorectal cancer, the presence of peritoneal metastases is a poor prognostic feature. Despite the improvement in systemic therapy, long-term survival remains poor for patients with peritoneal carcinomatosis. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can be associated with long-term survival in patients who have limited peritoneal disease, particularly those who can have complete cytoreduction. Whether the possible benefit of CRS and HIPEC is from the surgical resection of all disease or the combination of CRS and HIPEC remains unclear.
Details
- Title: Subtitle
- A Critical Look at Local-Regional Management of Peritoneal Metastasis
- Creators
- Carlos H.F Chan - Division of Surgical Oncology, Massachusetts General Hospital Cancer Center, Yawkey 7B, 55 Fruit Street, Boston, MA 02114, USAJames C Cusack - Division of Surgical Oncology, Massachusetts General Hospital Cancer Center, Yawkey 7B, 55 Fruit Street, Boston, MA 02114, USADavid P Ryan - Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Yawkey 7B, 55 Fruit Street, Boston, MA 02114, USA
- Resource Type
- Journal article
- Publication Details
- Hematology/oncology clinics of North America, Vol.29(1), pp.153-158
- Publisher
- Elsevier Inc
- DOI
- 10.1016/j.hoc.2014.09.006
- PMID
- 25475577
- ISSN
- 0889-8588
- eISSN
- 1558-1977
- Language
- English
- Date published
- 02/2015
- Academic Unit
- Surgery; Radiation Oncology
- Record Identifier
- 9984047975902771
Metrics
24 Record Views